Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Explorative randomized crossover study of oral cannabidiol on CNS and cortical excitability in healthy males
2023-508311-23-00Phase 2Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol (3 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Saccadic eye movements, Smooth pursuit eye movements and 7 more. Started Nov 2023; status: completed.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on 2023-508311-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508311-23-00.